2023
Social Determinants, Cardiovascular Disease, and Health Care Cost: A Nationwide Study in the United States Using Machine Learning
Sun F, Yao J, Du S, Qian F, Appleton A, Tao C, Xu H, Liu L, Dai Q, Joyce B, Nannini D, Hou L, Zhang K. Social Determinants, Cardiovascular Disease, and Health Care Cost: A Nationwide Study in the United States Using Machine Learning. Journal Of The American Heart Association 2023, 12: e027919. PMID: 36802713, PMCID: PMC10111459, DOI: 10.1161/jaha.122.027919.Peer-Reviewed Original Research
2022
Associations Between Vascular Diseases and Alzheimer’s Disease or Related Dementias in a Large Cohort of Men and Women with Colorectal Cancer
Du X, Song L, Schulz P, Xu H, Chan W. Associations Between Vascular Diseases and Alzheimer’s Disease or Related Dementias in a Large Cohort of Men and Women with Colorectal Cancer. Journal Of Alzheimer's Disease 2022, 90: 211-231. PMID: 36093703, PMCID: PMC9661325, DOI: 10.3233/jad-220548.Peer-Reviewed Original ResearchConceptsColorectal cancerVascular diseaseCardiovascular diseaseAlzheimer's diseaseRisk of ADSignificant dose-response relationshipRetrospective cohort studyCohort of patientsTypes of dementiaLong-term riskDose-response relationshipRisk of ADRDTumor factorsCohort studyCumulative incidenceOlder patientsLarge cohortPatientsRelated dementiaHypertensionCancerDiseaseDiabetesDementiaStrokeFactors Associated With COVID-19 Death in the United States: Cohort Study
Chen U, Xu H, Krause T, Greenberg R, Dong X, Jiang X. Factors Associated With COVID-19 Death in the United States: Cohort Study. JMIR Public Health And Surveillance 2022, 8: e29343. PMID: 35377319, PMCID: PMC9132142, DOI: 10.2196/29343.Peer-Reviewed Original ResearchMeSH KeywordsAdultBlack or African AmericanCohort StudiesCOVID-19HumansMaleMiddle AgedSARS-CoV-2United StatesWhite PeopleConceptsCOVID-19-related deathsCohort studyPatient characteristicsElectronic health record data setsLarge national cohort studyNational cohort studyChronic respiratory diseasesProportional hazards modelCOVID-19COVID-19 deathsImmunosuppressive conditionsKidney functionMale sexLung cancerCOVID-19 casesRecent diagnosisRisk factorsRespiratory diseaseCardiac diseaseOrgan transplantsHigh incidenceHazards modelNeurological diseasesOlder ageDiseaseRisk of Developing Alzheimer’s Disease and Related Dementias in Association with Cardiovascular Disease, Stroke, Hypertension, and Diabetes in a Large Cohort of Women with Breast Cancer and with up to 26 Years of Follow-Up
Du X, Song L, Schulz P, Xu H, Chan W. Risk of Developing Alzheimer’s Disease and Related Dementias in Association with Cardiovascular Disease, Stroke, Hypertension, and Diabetes in a Large Cohort of Women with Breast Cancer and with up to 26 Years of Follow-Up. Journal Of Alzheimer's Disease 2022, 87: 415-432. PMID: 35311707, PMCID: PMC9117151, DOI: 10.3233/jad-215657.Peer-Reviewed Original ResearchConceptsCardiovascular diseaseBreast cancerAsian/Pacific IslandersHigh riskAlzheimer's diseaseRisk of ADRDCumulative incidenceWhite womenLong-term incidencePacific IslandersBlack womenVascular diseaseHypertensionLarge cohortLower riskDiabetesRelated dementiaStrokeCancerDiseaseADRDCancer diagnosisWomenIncidenceRisk
2021
Nonselective beta‐blockers are associated with a lower risk of hepatocellular carcinoma among cirrhotic patients in the United States
Wijarnpreecha K, Li F, Xiang Y, Xu X, Zhu C, Maroufy V, Wang Q, Tao W, Dang Y, Pham H, Zhou Y, Li J, Zhang X, Xu H, Taner C, Yang L, Tao C. Nonselective beta‐blockers are associated with a lower risk of hepatocellular carcinoma among cirrhotic patients in the United States. Alimentary Pharmacology & Therapeutics 2021, 54: 481-492. PMID: 34224163, DOI: 10.1111/apt.16490.Peer-Reviewed Original ResearchConceptsRisk of HCCBeta-blocker groupHepatocellular carcinomaCirrhotic patientsCerner Health Facts databaseCox proportional hazards regressionCumulative HCC incidenceRetrospective cohort studyHealth Facts databasePopulation-based studyProportional hazards regressionKaplan-Meier estimatesEligible patientsCohort studyHCC incidenceFinal cohortHazards regressionHCC riskLower riskPropensity scorePatientsCarvedilolRiskFacts databaseGroupThe application of artificial intelligence and data integration in COVID-19 studies: a scoping review
Guo Y, Zhang Y, Lyu T, Prosperi M, Wang F, Xu H, Bian J. The application of artificial intelligence and data integration in COVID-19 studies: a scoping review. Journal Of The American Medical Informatics Association 2021, 28: 2050-2067. PMID: 34151987, PMCID: PMC8344463, DOI: 10.1093/jamia/ocab098.Peer-Reviewed Original ResearchConceptsAI applicationsArtificial intelligenceData integrationHeterogeneous dataSocial media data analysisMost AI applicationsHeterogeneous data sourcesMedia data analysisProteomics data analysisAI algorithmsAI frameworkElectronic health recordsHeterogenous dataBiased algorithmsHealth recordsCOVID-19 researchData analysisSingle-source approachResearch topicData sourcesResearch areaIntelligenceSurveillance systemDifferent sourcesAlgorithmExtracting postmarketing adverse events from safety reports in the vaccine adverse event reporting system (VAERS) using deep learning
Du J, Xiang Y, Sankaranarayanapillai M, Zhang M, Wang J, Si Y, Pham H, Xu H, Chen Y, Tao C. Extracting postmarketing adverse events from safety reports in the vaccine adverse event reporting system (VAERS) using deep learning. Journal Of The American Medical Informatics Association 2021, 28: 1393-1400. PMID: 33647938, PMCID: PMC8279785, DOI: 10.1093/jamia/ocab014.Peer-Reviewed Original ResearchConceptsDeep learning algorithmsLearning-based methodsVaccine Adverse Event Reporting SystemLearning algorithmArt deep learning algorithmsDeep learning-based methodsConventional machine learning-based methodsMachine learning-based methodsConventional machine learningAdverse Event Reporting SystemGuillain-Barré syndromeLarge modelsAdverse eventsEvent Reporting SystemVAERS reportsDeep learningMachine learningEntity recognitionPeer modelInfluenza vaccine safetyNervous system disordersExact matchVaccine adverse eventsSafety reportsReporting system
2020
The UMLS knowledge sources at 30: indispensable to current research and applications in biomedical informatics
Humphreys B, Del Fiol G, Xu H. The UMLS knowledge sources at 30: indispensable to current research and applications in biomedical informatics. Journal Of The American Medical Informatics Association 2020, 27: 1499-1501. PMID: 33059366, PMCID: PMC7647371, DOI: 10.1093/jamia/ocaa208.Peer-Reviewed Original ResearchCoronavirus: indexed data speed up solutions
Ohno-Machado L, Xu H. Coronavirus: indexed data speed up solutions. Nature 2020, 584: 192-192. PMID: 32782375, DOI: 10.1038/d41586-020-02331-3.Commentaries, Editorials and Letters
2017
A systematic analysis of FDA-approved anticancer drugs
Sun J, Wei Q, Zhou Y, Wang J, Liu Q, Xu H. A systematic analysis of FDA-approved anticancer drugs. BMC Systems Biology 2017, 11: 87. PMID: 28984210, PMCID: PMC5629554, DOI: 10.1186/s12918-017-0464-7.Peer-Reviewed Original ResearchConceptsDrug-cancer associationsAnticancer drugsTarget-based drugsEfficient anticancer drugsTarget-based approachCancer typesNew anticancer drugsNovel anticancer drugsClinical trial studyPharmaceutical researchTrial studyMore cancer typesUS FoodDrug AdministrationCytotoxic drugsPatient treatmentPotential candidateDrug mechanismsDrugsDrug repurposingSystematic investigationAssociationDrug targetsTyrosine kinaseSystematic discoveryAccurate Identification of Fatty Liver Disease in Data Warehouse Utilizing Natural Language Processing
Redman J, Natarajan Y, Hou J, Wang J, Hanif M, Feng H, Kramer J, Desiderio R, Xu H, El-Serag H, Kanwal F. Accurate Identification of Fatty Liver Disease in Data Warehouse Utilizing Natural Language Processing. Digestive Diseases And Sciences 2017, 62: 2713-2718. PMID: 28861720, DOI: 10.1007/s10620-017-4721-9.Peer-Reviewed Original ResearchConceptsData warehouseFatty liver diseaseLanguage processingNatural language processingLiver diseaseF-measureAlgorithm developmentVeterans Affairs Corporate Data WarehouseMagnetic resonance imaging reportsOutcomes of patientsAlgorithmExpert radiologistsValidation methodElectronic medical recordsCorporate Data WarehouseWarehouseAbdominal ultrasoundManual reviewHepatic steatosisMedical recordsRandom national sampleClinical studiesLarge cohortComputerized tomographyImaging reportsEvaluating the role of race and medication in protection of uterine fibroids by type 2 diabetes exposure
Velez Edwards D, Hartmann K, Wellons M, Shah A, Xu H, Edwards T. Evaluating the role of race and medication in protection of uterine fibroids by type 2 diabetes exposure. BMC Women's Health 2017, 17: 28. PMID: 28399866, PMCID: PMC5387248, DOI: 10.1186/s12905-017-0386-y.Peer-Reviewed Original ResearchConceptsT2D medicationsUF riskAnnual healthcare costsElectronic medical record algorithmCase-control studyLarge clinical populationFurther mechanistic researchBackgroundUterine fibroidsT2D diagnosisDiabetes exposureMedication typeDiabetes presenceInsulin usersUterine fibroidsInsulin treatmentProtective associationStratified analysisClinical cohortConclusionsThese dataProtective effectLarge cohortCase-control statusHealthcare costsT2DMedicationsComparing Cancer Information Needs for Consumers in the US and China.
Ji Z, Zhang Y, Xu J, Chen X, Wu Y, Xu H. Comparing Cancer Information Needs for Consumers in the US and China. 2017, 245: 126-130. PMID: 29295066, PMCID: PMC5805146.Peer-Reviewed Original Research
2015
Effects of Health Insurance on Tumor Stage, Treatment, and Survival in Large Cohorts of Patients with Breast and Colorectal Cancer
Zhang Y, Franzini L, Chan W, Xu H, Du X. Effects of Health Insurance on Tumor Stage, Treatment, and Survival in Large Cohorts of Patients with Breast and Colorectal Cancer. Journal Of Health Care For The Poor And Underserved 2015, 26: 1336-1358. PMID: 26548682, DOI: 10.1353/hpu.2015.0119.Peer-Reviewed Original ResearchConceptsRisk of mortalityColorectal cancerTumor stagePrivate health insuranceCancer patientsHealth insuranceCancer-directed surgeryColorectal cancer patientsTexas Cancer RegistryInsurance coverageAdditional private health insuranceBreast cancer patientsHealth insurance statusHealth insurance coverageOverall survivalCancer RegistryInsurance statusBreast cancerLarge cohortHigh riskMedicare beneficiariesPatientsCancerChemotherapySurgeryTrends and variations in breast and colorectal cancer incidence from 1995 to 2011: A comparative study between Texas Cancer Registry and National Cancer Institute’s Surveillance, Epidemiology and End Results data
LIU Z, ZHANG Y, FRANZIN L, CORMIER J, CHAN W, XU H, DU X. Trends and variations in breast and colorectal cancer incidence from 1995 to 2011: A comparative study between Texas Cancer Registry and National Cancer Institute’s Surveillance, Epidemiology and End Results data. International Journal Of Oncology 2015, 46: 1819-1826. PMID: 25672365, PMCID: PMC4356494, DOI: 10.3892/ijo.2015.2881.Peer-Reviewed Original ResearchConceptsColorectal cancer incidenceNational Cancer Institute's SurveillanceTexas Cancer RegistryBreast cancer incidenceCancer incidenceCancer RegistryAge-adjusted breast cancer incidenceColorectal cancer patientsEnd Results (SEER) dataSEER areasColorectal cancerCancer patientsIncidence rateRelative riskIncidenceBreastRegistrySurveillanceEpidemiologySEERResult dataTemporal trendsEnd resultPatientsParallel comparison
2014
Network‐Assisted Prediction of Potential Drugs for Addiction
Sun J, Huang L, Xu H, Zhao Z. Network‐Assisted Prediction of Potential Drugs for Addiction. BioMed Research International 2014, 2014: 258784. PMID: 24689033, PMCID: PMC3932722, DOI: 10.1155/2014/258784.Peer-Reviewed Original Research
2013
Analyzing differences between chinese and english clinical text: a cross-institution comparison of discharge summaries in two languages.
Wu Y, Lei J, Wei W, Tang B, Denny J, Rosenbloom S, Miller R, Giuse D, Zheng K, Xu H. Analyzing differences between chinese and english clinical text: a cross-institution comparison of discharge summaries in two languages. 2013, 192: 662-6. PMID: 23920639, PMCID: PMC4957806.Peer-Reviewed Original ResearchConceptsNatural language processing toolsEnglish clinical textClinical textLanguage processing toolsChinese clinical textCultural differencesMajor clinical componentsTextWestern institutionsInpatient discharge summariesCross-country collaborationDocument levelProcessing toolsClinical documentsLanguageUS institutionsUsesUnprecedented amountValuable insightsInstitutionsDocumentsChinaWorldwide adoptionEMR dataCollaboration
2012
Electronic Medical Records as a Tool in Clinical Pharmacology: Opportunities and Challenges
Roden D, Xu H, Denny J, Wilke R. Electronic Medical Records as a Tool in Clinical Pharmacology: Opportunities and Challenges. Clinical Pharmacology & Therapeutics 2012, 91: 1083-1086. PMID: 22534870, PMCID: PMC3819803, DOI: 10.1038/clpt.2012.42.Peer-Reviewed Original ResearchMeSH KeywordsElectronic Health RecordsGeneticsHumansPharmacogeneticsPharmacology, ClinicalPhenotypeUnited States
2011
Facilitating pharmacogenetic studies using electronic health records and natural-language processing: a case study of warfarin
Xu H, Jiang M, Oetjens M, Bowton E, Ramirez A, Jeff J, Basford M, Pulley J, Cowan J, Wang X, Ritchie M, Masys D, Roden D, Crawford D, Denny J. Facilitating pharmacogenetic studies using electronic health records and natural-language processing: a case study of warfarin. Journal Of The American Medical Informatics Association 2011, 18: 387-391. PMID: 21672908, PMCID: PMC3128409, DOI: 10.1136/amiajnl-2011-000208.Peer-Reviewed Original ResearchAlgorithmsAnticoagulantsAryl Hydrocarbon HydroxylasesCytochrome P-450 CYP2C9Data MiningDatabases, Nucleic AcidDrug Dosage CalculationsElectronic Health RecordsGenome-Wide Association StudyHumansLinear ModelsMixed Function OxygenasesNatural Language ProcessingPharmacogeneticsPrecision MedicineUnited StatesVitamin K Epoxide ReductasesWarfarin